Celling Blog

Autologous Stem Cell Medical Devices


June 1, 2017

Let’s Talk About PRP

Y’all know what I love? Open access science, that’s what. And that’s why this week’s good news about cell therapy comes from an article that’s freely available to every single one of you, right here on the regular old internet. This study actually came out about a year ago, but I think it deserves a little more attention than it’s received thus far. Here’s why: this study executed a head to head comparison of hyaluronic acid (HA) injections (aka viscosupplementation) and platelet rich plasma (PRP), which is frequently a topic of conversation with doctor and patients. The authors concluded that PRP achieved longer lasting results in all patients and was more effective in reducing pain and disability (as measure by a quality of life scale) in patients with less severe arthritis. – Read More –

January 19, 2017

Seriously Y’all, Stop With The Antibiotic Abuse

Hello readers, it’s Dr. Richard Suzuki again and I’ll be writing today’s Celling blog.  I’d like to discuss the recent surge of media attention surrounding antibiotic-resistant bacteria resulting from the unfortunate case of a 70-year old woman who died in Washoe County, Nevada. Dr. Moncivais has discussed the subject of antibiotic-resistant bacteria in a previous blog, but given the renewed discussion over these “superbugs” as they care called, I thought it would be timely to re-address the subject. – Read More –

November 29, 2016

Latest Advances in Regenerative Medicine

Regenerative medicine has sprouted many fascinating therapies and is gaining popularity in the field of medicine for spine and orthopedic applications.  Regenerative medicine is an umbrella term for many treatments, and I will cover the adult stem cell therapy derived from autologous bone marrow concentrate (stem cells and immune cells concentrated from a patient’s own bone marrow).  Below are some of my favorite 2016 publications that show the latest advances in regenerative medicine. – Read More –

July 23, 2015

More Disappearing MSCs

In my last post I reviewed a couple of examples provided by Dr. Philippe Hernigou (Chief of Orthopaedic Surgery, Henri-Mondor Hospital, University of Paris-East) from recent publications in which he reported on a loss of MSCs in bony tissues adjacent to an orthopedic pathology, like an osteonecrotic femoral head or rotator cuff tear. The post ended with a question about whether or not this linkage is also present in soft tissue pathologies.  – Read More –

July 21, 2015

Disappearing MSCs

Dr. Philippe Hernigou (Chief of Orthopaedic Surgery, Henri-Mondor Hospital, University of Paris-East) gave several presentations at the recent TOBI Conference. During one of those presentations he commented on the negative influence a pathologic site has on the MSC content in adjacent tissues. The concept is simple: a site of orthopedic injury, like avascular necrosis (AVN) of the femoral head (also known as osteonecrosis of the femoral head, ONFL), will be deficient in its MSC content compared to a normal femoral head. But the deficiency isn’t limited to the actual site of pathology, since it appears there is a measurable reduction in the level of MSCs in tissues adjacent to the actual pathology.  – Read More –

Older Posts